Tirzepatide 30mg Vial | Aura Peptides Official UK

The Tirzepatide 30mg Vial by Aura Peptides is a high-purity, lyophilized dual GIP and GLP-1 receptor agonist engineered specifically for advanced metabolic, glycemic, and endocrine research applications in the UK. Supplied as a vacuum-sealed, freeze-dried powder, this 30mg vial format provides laboratory researchers with full control over reconstitution volumes, diluent buffers, and concentration parameters for quantitative assays.

Every batch of Aura Peptides Tirzepatide 30mg is manufactured under strict analytical quality controls and independently tested using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to guarantee purity ratings exceeding 98.0%.

Technical Specifications: Tirzepatide 30mg Research Vial

Key Advantages of the Lyophilized 30mg Vial Format

When conducting laboratory research on Tirzepatide 30mg in the UK, selecting a freeze-dried vial format offers key logistical and experimental benefits over pre-filled liquid devices:

• Custom Concentration Control: Enables researchers to reconstitute the peptide matrix using exact volumes of Bacteriostatic Water or Sterile Saline tailored to specific micromolar assay setups.

• Extended Storage Stability: Freeze-drying preserves peptide structural integrity over longer shelf-life intervals when stored at sub-zero temperatures.

• Vacuum-Sealed Protection: Sealed under inert atmosphere to protect the 39-amino-acid synthetic sequence against ambient humidity and oxidative degradation prior to use.

Mechanism of Action: Dual GIP & GLP-1 Agonism

Tirzepatide is a synthetic peptide engineered to engage both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously:

                      ┌───────────────────────────────┐
                      │   Tirzepatide 30mg Sequence   │
                      └───────────────┬───────────────┘
                                      │
                   ┌──────────────────┴──────────────────┐
                   ▼                                     ▼
      ┌─────────────────────────┐           ┌─────────────────────────┐
      │      GIP Receptor       │           │     GLP-1 Receptor      │
      │  (Lipid & Energy Drive) │           │ (Glycemic & Appetite)   │
      └─────────────────────────┘           └─────────────────────────┘

1. GIP Receptor Signaling: Enhances glucose-dependent insulin secretion, regulates lipid metabolism, and acts synergistically with GLP-1 pathways in cellular models.

2. GLP-1 Receptor Signaling: Modulates glucose homeostasis, delays gastric motility parameters, and regulates central appetite pathways in metabolic trials.

Reconstitution & Laboratory Handling Protocols

To protect fragile peptide bonds and preserve structural integrity during laboratory prep:

1. Temperature Equilibration: Allow the freeze-dried vial to reach room temperature before injecting liquid diluent to avoid thermal stress.

2. Diluent Introduction: Gently introduce Bacteriostatic Water or Sterile Saline along the inner glass wall of the vial rather than directly onto the lyophilized cake.

3. Gentle Dissolution: Swirl the vial in smooth, circular motions until completely clear. Avoid vigorous shaking, as mechanical agitation can shear delicate peptide chains.

Quality Assurance & Certificate of Analysis (CoA)

At Aura Peptides Official UK, quality verification and analytical accuracy are foundational:

• HPLC Mass Purity: Confirms single-peak baseline separation, ensuring zero synthesis side-products or truncated sequences.

• Mass Spectrometry (MS): Validates the exact molecular mass identity ($\text{MW} \approx 4813.45\text{ g/mol}$) against baseline reference standards.

• Documentation: Batch-specific Certificates of Analysis (CoAs) are accessible for verified research users upon request.

Frequently Asked Questions

What is the difference between the Tirzepatide 30mg vial and the 30mg pen?

The vial format contains lyophilized freeze-dried powder requiring manual reconstitution, allowing full flexibility over diluent choice and volumetric concentration. The pen format contains a pre-formulated liquid cartridge designed for calibrated micro-dosing.

How should the un-reconstituted Tirzepatide 30mg vial be stored?

Un-reconstituted freeze-dried vials should be stored frozen at or below -20°C, protected from light. Once reconstituted, store the liquid solution refrigerated between 2°C and 8°C.

Compliance & Regulatory Notice

Laboratory Notice: All products supplied by aurapeptides.uk, including Tirzepatide 30mg Vials, are strictly intended for laboratory in vitro research, analytical evaluation, and scientific inquiry. They are not intended for human consumption, clinical administration, medical diagnosis, or therapeutic use.